In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rennova Health Inc. (NASDAQ:RNVA) reported that Sramowicz Steven has picked up 3,855,659 of common stock as of 2017-02-01.

The acquisition brings the aggregate amount owned by Sramowicz Steven to a total of 3,855,659 representing a 23.0% stake in the company.

For those not familiar with the company, Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

A glance at Rennova Health Inc. (NASDAQ:RNVA)’s key stats reveals a current market capitalization of 4.86 million based on 84.01 million shares outstanding and a price at last close of $0.070 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-07-14, Diamantis picked up 333,333 at a purchase price of $0.44. This brings their total holding to 681,526  as of the date of the filing.

On the sell side, the most recent transaction saw Alcatel-Lucent unload 7,843 shares at a sale price of $4.60. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rennova Health Inc. (NASDAQ:RNVA) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.